MedPath

Stroke Rehabilitation: A Systemized and Hierarchized Rehabilitation Program for the Brazilian Unified Health System

Not Applicable
Not yet recruiting
Conditions
Stroke, Ischemic
Interventions
Other: Conventional rehabilitation program.
Other: Innovative rehabilitation
Registration Number
NCT06494202
Lead Sponsor
University of Sao Paulo
Brief Summary

The goal of this clinical trial is to systemize and hierarchize a rehabilitation program for the Brazilian Unified Health System in patients with stroke above 18 years of age and of both sexes. The main question it aims to answer is:

* Do patients with ischemic first episode of stroke have central nervous systems consequences due to peripheral and central nervous system sensibilization?

* Can stroke patients benefit from a systemized and hierarchized rehabilitation program with desensibilization interventions combined with multidisciplinary and educational programs?

We will randomize 60 patients, 30 in each study arm.

Researchers will compare the intervention group with an active control whose treatment is the institutional conventional program to see if innovative desensibilization strategies yield superior results. Authors will also investigate the role of genetic polymorphism and ancestrality in the outcome measures.

Participants will undertake an innovative or conventional rehabilitation program, according to the randomization.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Clinical and radiological (magnetic resonance or tomography) diagnosis of ischemic stroke;
  • Single episode of stroke;
  • Clinical stability according to medical assessment;
  • Time since stroke onset no longer than 24 months;
  • Capacity to understand the study procedures;
  • Eligible to be admitted to hospitalization at the institute where the study will be conducted
  • Agree to sign the Informed Consent Form (ICF).
Exclusion Criteria
  • Presence of psychiatric disorders;
  • Presence of subarachnoid hemorrhage;
  • Presence of intracerebral hemorrhage;
  • Presence of neuromuscular disorders;
  • Presence of other neurological diseases or brain neoplasm;
  • Presence of cognitive disorders measured with Montreal Cognitive Assessment (MoCA), scores below 20 points;
  • Presence of systemic arterial hypertension (systolic blood pressure ≥ 185mmHg or diastolic blood pressure ≥ 110 mmHg).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Conventional rehabilitation programConventional rehabilitation program.Conventional rehabilitation intervention with multidisciplinary team (medical services, physiotherapy, occupational therapy, physical education, psychology, nutrition, social service, speech therapy, and nurse) delivered during four to six weeks of intensive in-patient program
Innovative rehabilitation programConventional rehabilitation program.Conventional rehabilitation intervention with multidisciplinary team (medical services, physiotherapy, occupational therapy, physical education, psychology, nutrition, social service, speech therapy, and nurse) delivered during four to six weeks of intensive in-patient program combined with innovative medical therapies (laser therapy, radial extracorporeal shockwaves therapy, focused extracorporeal shockwaves therapy, segmentary desensibilization with lidocaine, functional electrical stimulation - FES).
Innovative rehabilitation programInnovative rehabilitationConventional rehabilitation intervention with multidisciplinary team (medical services, physiotherapy, occupational therapy, physical education, psychology, nutrition, social service, speech therapy, and nurse) delivered during four to six weeks of intensive in-patient program combined with innovative medical therapies (laser therapy, radial extracorporeal shockwaves therapy, focused extracorporeal shockwaves therapy, segmentary desensibilization with lidocaine, functional electrical stimulation - FES).
Primary Outcome Measures
NameTimeMethod
Motor recoveryChange from baseline to six weeks of intervention.

Motor recovery measured with Fugl-Meyer Assessment (FMA), ranging from 0 to 100 for upper and lower extremities combined. Higher scores mean better outcome.

Secondary Outcome Measures
NameTimeMethod
Upper extremity recoveryChange from baseline to six weeks of intervention.

Finger movement measured with Finger Tapping assessement. The finger tapping assessment measures the number index finger movements (up and down) performed for one minute.

Spasticity reductionChange from baseline to six weeks of intervention.

Upper limbs spasticity measured with Modified Ashworth Scale (MAS). The MAS ranges from 0 to 4, and higher scores mean worse outcomes.

Gait recoveryChange from baseline to six weeks of intervention.

Gait recovery measured with 10-meter walk test (10mwt).

Quality of life after strokeChange from baseline to six weeks of intervention.

Quality of Life after stroke measured with Stroke Impact Scale (SIS). The SIS ranges from 0 to 100 and higher scores mean better outcomes.

Functional independenceChange from baseline to six weeks of intervention.

Functional independence measured with Functional Independence Measure (FIM). This scale ranges from 18 to 126, and higher scores mean better outcomes.

Muscle strengthChange from baseline to six weeks of intervention.

Muscle strength measured Medical Research Council scale (MRC). The MRC is a scale that ranges from 0 to 5 and higher scores mean better outcomes.

Gait and balance recoveryChange from baseline to six weeks of intervention.

Gait and balance recovery measured with Timed Up and Go (TUG).

Pain assessmentChange from baseline to six weeks of intervention.

Pain intensity measured with Visual Analogue Scale (VAS). The VAS is a linear approximation of pain intensity ranging from 0 to 10 and higher scores mean worse outcomes.

Sensibilization assessmentChange from baseline to six weeks of intervention.

Sensibilization assessment conducted with Pain Pressure Threshold (PPT).

Trial Locations

Locations (1)

Instituto de Medicina Física e Reabilitação (IMREA-FMUSP)

🇧🇷

São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath